SCHEMBL9493463

SCHEMBL9493463

COc1cccc(C2(OC(=O)C(=O)O)CN3CCCC2C3)c1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.50
SLC6A2 P23975 1/20 0.49
SLC6A3 Q01959 1/20 0.49
ALDH1A1 P00352 2/20 0.43
GRIN2B Q13224 2/20 0.39
KDM2B Q8NHM5 3/20 0.39
CTSD P07339 1/20 0.39
CTSE P14091 1/20 0.39
BACE1 P56817 1/20 0.39
OPRD1 P41143 2/20 0.38
OPRK1 P41145 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9492487 0.95 SLC6A4 (0.46) SLC6A4SLC6A2SLC6A3ALDH1A1GRIN2B
SCHEMBL9495675 0.89 ALDH1A1 (0.46) SLC6A4SLC6A2SLC6A3ALDH1A1GRIN2B
Oxalic Acid SCHEMBL9493456 0.81 SLC6A4 (0.53) SLC6A4SLC6A2SLC6A3ALDH1A1GRIN2B
SCHEMBL9493336 0.78 SLC6A4 (0.57) SLC6A4SLC6A2SLC6A3ALDH1A1OPRD1
Oxalic Acid SCHEMBL9492481 0.76 ALDH1A1 (0.48) SLC6A4SLC6A2SLC6A3ALDH1A1GRIN2B
Oxalic Acid SCHEMBL9495666 0.73 CHRM1 (0.50) SLC6A4SLC6A2SLC6A3ALDH1A1OPRD1
SCHEMBL9492441 0.73 CHRM2 (0.44) ALDH1A1KDM2BMEN1KMT2A
SCHEMBL9494634 0.72 SLC6A2 (0.43) SLC6A4SLC6A2SLC6A3ALDH1A1MEN1
SCHEMBL9492616 0.71 SLC6A4 (0.53) SLC6A4SLC6A2SLC6A3ALDH1A1OPRD1
SCHEMBL9493425 0.70 CHRM3 (0.45) OPRD1OPRK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5177084-A 1-Azabicycles, Treating Mental Disorders MERCK SHARP & DOHME LTD. (GB) 1993-01-05 US disclosed
EP-0412797-A2 The therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes MERCK SHARP & DOHME LTD. (GB) 1991-02-13 EP disclosed